-
A new multi-country study suggests that "Long Covid" is mostly from mild cases
Time of Update: 2023-02-02
Long crown refers to the persistence or development of symptoms three months after SARS-CoV-2 (the virus that causes new coronary pneumonia) first infection.
Long crown refers to the persistence or development of symptoms three months after SARS-CoV-2 (the virus that causes new coronary pneumonia) first infection.
-
KN026 Second-line treatment of HER2-expressing gastric cancer or gastroesophageal junction cancer results published in the internationally renowned journal EJC Press Release
Time of Update: 2023-01-05
Suzhou, China, November 23, 2022 – Corning Jerry Biopharmaceuticals (stock code: 9966. HK) and CSPC Pharmaceutical Group (stock code: 1093. HK) HK) jointly announced that the results of the phase II.
-
Rubber is expected to continue to rise in the future The market may first decline and then rise
Time of Update: 2022-12-21
However, the policy stimulus is still conducive to rubber demand after the year, although the tire inventory may not be large due to new energy consumption, but it will help the market recovery after the holiday.
-
Research: Sleep duration is indeed related to chronic diseases! How long to sleep each day is best for health
Time of Update: 2022-11-14
So how long to sleep each day is good for health?A new study published in PLOS Medicine found that sleeping less than 5 hours or more than 9 hours after age 50 is associated with an increased risk of diabetes, cancer, coronary heart disease, stroke, and other chronic diseases, as well as comorbidities (having two or more chronic diseases).
-
Golden sleep: Shorter sleep in later life is associated with multiple illnesses
Time of Update: 2022-10-25
"Our study, based on 25-year follow-up data from more than 7,000 men and women, reports that short sleep duration in middle-aged and older adults is associated with the risk of chronic disease and subsequent morbidity," Sabia added.
-
Anhua Jiutian Chemical laid the foundation for the project of 100,000 tons of methylamine per year
Time of Update: 2022-09-30
Zhang Shuihe, general manager of Henan Energy Group Chemical New Materials Company, said that the Anhua company's annual output of 100,000 tons of methylamine project can be successfully laid and implemented after nearly a year of preliminary preparations, which is inseparable from the leadership of the Long'an District Committee and District Government and the help and support of relevant departments.
-
As the first add-on treatment to metformin monotherapy, can DPP4i shake up the second-line treatment status of sulfonylureas
Time of Update: 2022-09-30
FDA and EMA approved incretin-line drugsThe results of clinical trials suggest that DPP4i has a positive risk/benefit balance in T2D therapy, and in different in vivo and in vitro studies, in addition to stimulating glucose-dependent insulin secretion, activation of GLP-1 receptors is also associated with increased proliferation of β cells and inhibition of apoptosis.
-
Harvard scientists propose new indicator of Alzheimer's disease that can predict the time and severity of onset
Time of Update: 2022-05-28
Lei Liu and colleagues at Harvard's Brigham and Women's Hospital found that lower Aβ37/Aβ42 ratios in cerebrospinal fluid were associated with earlier onset of symptoms in familial Alzheimer's disease associated with more severe cognitive impairment in sporadic Alzheimer's disease .
-
Investigation report: The national carbon market is expected to mature in five years
Time of Update: 2022-02-03
The report concluded that, judging from the survey results in recent years, people in the industry generally believe that the construction of a carbon emission trading system will have an increasing impact on investment decisions.
-
Brain: Sleeping for 10 hours a day or sluggish
Time of Update: 2021-11-01
The results show that even after adjusting for age, CSF total tau/Aβ42 ratio, APOE ε4 carrier status, years of education, and gender, sleep time alone is enough to affect the changes in brain cognitive abilities—at 7-8 hours of sleep duration The risk of cognitive impairment is the lowest .
-
2021ASCO express lenvatinib: multi-tumor evidence unfolds, demonstrating excellent efficacy
Time of Update: 2021-06-17
8LEAP-005: Lenvatinib + Pembrolizumab highlights the potential for the treatment of gastrointestinal tumors LEAP-005 (NCT03797326) is a phase II, multi-cohort, non-randomized, open-label study designed to evaluate lenvatinib+ The efficacy and safety of pembrolizumab in patients with advanced solid tumors who have previously received treatment, this time ASCO announced the LEAP-005 gastric cancer cohort (abstract number: 4030), colorectal cancer cohort (abstract number: 3564) and The results of the cholangiocarcinoma cohort (abstract number: 4080) .
-
J Clin Invest: A persistent cellular immune disorder occurs in patients recovering from SARS-CoV-2 infection
Time of Update: 2021-02-02
a recent study published in J Clin Invest, researchers looked at the subgengies of immune cells in both hospitalized and non-hospitalized patients and found that patients with immune disorders after SARS-CoV-2 infection took longer to develop, and more research was needed to investigate immune disorders in patients.
-
The harm of food with high additive content to children
Time of Update: 2015-10-19
Introduction: there are many kinds of food for children now Parents should pay attention to the intake of color food when purchasing food for children, because some color food may be added too much fo
-
The first choice of prophylactic drugs for migraine caused by the extract of Scutellaria and topiramate
Time of Update: 2012-04-26
Recently, the latest migraine prevention and treatment guidelines of the American Academy of Neurology (AAN) and the American Headache Society (AHS) listed topiramate and butterbur extract together wi
